RE: TAIWAN Marketing Authorization Approval15 Dec 2020 07:27
Heimdal,
Although DLI received 3.79 mill USD from their series A placing, this money now becomes available for use by RPG (at a cost of 12 mill USD to us shareholders), however. Although that money was meant to be used for the running costs of DLI, if RPG now take control of those funds to use elsewhere like pay the ATO, where does that leave DLI with no money ? Non of it appears to add up with respect to monies owed to JM, ATO costs, JG's outrageous salary and FDA phase 2 completion and FDA phase III commencement. As far as I can see the company is still short of cash.....no ?